Alkem Laboratories Launches A to Z Daily Multivitamin Supplement

Alkem Laboratories Ltd. has announced the launch of a new product, A to Z Daily, which is a multivitamin supplement formulated for adults. This product is designed to provide holistic nutritional support to both the body and mind. The supplement includes a total of 26 essential vitamins, minerals, and botanicals. Key components such as Vitamin B complex, Vitamin D3, Vitamin C, Zinc, and Iron are included to help boost energy levels, reduce fatigue, and improve immunity.

The financial details regarding the launch of A to Z Daily have not been disclosed in the filing. The focus of the announcement is on the product’s composition and intended benefits rather than financial metrics or projections. The supplement is positioned as a long-term, consistent support for maintaining physical energy and mental composure.

The operational scope of A to Z Daily includes its formulation with clinically-researched botanicals such as Ashwagandha, Bacopa monnieri (Brahmi), Panax ginseng, and the amino acid L-theanine. These ingredients are intended to assist in managing stress and anxiety, improving sleep quality, and supporting cognitive function. Unlike conventional multivitamins, A to Z Daily is designed for everyday use to maintain overall vitality and manage daily stress.

In the context of market relevance, the product is approved by the Food Safety Standards Authority of India (FSSAI) and is a 100% vegetarian product. It provides 100% of the recommended daily allowance (RDA) of 19 vitamins and minerals, aiming to bridge common dietary gaps and support overall nutritional adequacy in adults. The product is part of Alkem’s strategy to address the increasing demands on both physical health and mental well-being due to modern lifestyles.

The timeline for the product’s availability and distribution has not been specified in the filing. The announcement focuses on the product’s launch and its intended benefits for consumers. The filing does not mention any specific milestones or implementation dates related to the product’s rollout.

Alkem Laboratories Ltd. is a leading Indian pharmaceutical company with a 50-year legacy in providing high-quality medicines. It holds a significant position in the Indian market, particularly in therapy areas such as anti-infectives, gastrointestinal, and pain management drugs. The company also has a growing portfolio in chronic therapies, including diabetes, neurology, and cardiology. Alkem operates 18 manufacturing facilities and research and development centers across India and the US, focusing on developing generic formulations, active pharmaceutical ingredients, and biosimilars.